nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—lung cancer	0.236	1	CbGaD
Desloratadine—CYP2C19—Gefitinib—lung cancer	0.0372	0.0703	CbGbCtD
Desloratadine—CYP2C19—Teniposide—lung cancer	0.0361	0.0681	CbGbCtD
Desloratadine—ABCB1—Topotecan—lung cancer	0.0328	0.062	CbGbCtD
Desloratadine—CYP2C9—Gefitinib—lung cancer	0.0309	0.0584	CbGbCtD
Desloratadine—ABCB1—Gefitinib—lung cancer	0.03	0.0567	CbGbCtD
Desloratadine—CYP2C9—Teniposide—lung cancer	0.03	0.0567	CbGbCtD
Desloratadine—CYP2D6—Gefitinib—lung cancer	0.0283	0.0534	CbGbCtD
Desloratadine—ABCB1—Vinorelbine—lung cancer	0.0231	0.0437	CbGbCtD
Desloratadine—CYP2D6—Vinorelbine—lung cancer	0.0218	0.0412	CbGbCtD
Desloratadine—CYP1A2—Erlotinib—lung cancer	0.0203	0.0383	CbGbCtD
Desloratadine—ABCB1—Crizotinib—lung cancer	0.0184	0.0348	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—lung cancer	0.018	0.034	CbGbCtD
Desloratadine—ABCB1—Erlotinib—lung cancer	0.0178	0.0335	CbGbCtD
Desloratadine—CYP2C9—Paclitaxel—lung cancer	0.0168	0.0316	CbGbCtD
Desloratadine—CYP2D6—Erlotinib—lung cancer	0.0167	0.0316	CbGbCtD
Desloratadine—ABCB1—Paclitaxel—lung cancer	0.0163	0.0307	CbGbCtD
Desloratadine—ABCB1—Irinotecan—lung cancer	0.016	0.0303	CbGbCtD
Desloratadine—CYP1A2—Etoposide—lung cancer	0.0147	0.0277	CbGbCtD
Desloratadine—ABCB1—Vinblastine—lung cancer	0.0143	0.0269	CbGbCtD
Desloratadine—CYP2C9—Cisplatin—lung cancer	0.0135	0.0254	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—lung cancer	0.0134	0.0254	CbGbCtD
Desloratadine—ABCB1—Cisplatin—lung cancer	0.0131	0.0247	CbGbCtD
Desloratadine—ABCB1—Etoposide—lung cancer	0.0128	0.0243	CbGbCtD
Desloratadine—ABCB1—Docetaxel—lung cancer	0.0118	0.0222	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—lung cancer	0.00876	0.0165	CbGbCtD
Desloratadine—ABCB1—Methotrexate—lung cancer	0.00849	0.016	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—lung cancer	0.00825	0.0156	CbGbCtD
Desloratadine—Hypersensitivity—Vinorelbine—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Dermatitis—Topotecan—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Vomiting—Erlotinib—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Dyspnoea—Irinotecan—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Nervous system disorder—Cisplatin—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Cough—Etoposide—lung cancer	0.000208	0.00132	CcSEcCtD
Desloratadine—Somnolence—Irinotecan—lung cancer	0.000207	0.00132	CcSEcCtD
Desloratadine—Headache—Topotecan—lung cancer	0.000207	0.00131	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000207	0.00131	CcSEcCtD
Desloratadine—Tachycardia—Cisplatin—lung cancer	0.000207	0.00131	CcSEcCtD
Desloratadine—Rash—Erlotinib—lung cancer	0.000206	0.00131	CcSEcCtD
Desloratadine—Dermatitis—Erlotinib—lung cancer	0.000206	0.00131	CcSEcCtD
Desloratadine—Palpitations—Paclitaxel—lung cancer	0.000206	0.00131	CcSEcCtD
Desloratadine—Convulsion—Etoposide—lung cancer	0.000206	0.00131	CcSEcCtD
Desloratadine—Insomnia—Gemcitabine—lung cancer	0.000206	0.0013	CcSEcCtD
Desloratadine—Dyspepsia—Irinotecan—lung cancer	0.000205	0.0013	CcSEcCtD
Desloratadine—Headache—Erlotinib—lung cancer	0.000205	0.0013	CcSEcCtD
Desloratadine—Cough—Paclitaxel—lung cancer	0.000203	0.00129	CcSEcCtD
Desloratadine—Asthenia—Vinorelbine—lung cancer	0.000203	0.00129	CcSEcCtD
Desloratadine—Decreased appetite—Irinotecan—lung cancer	0.000203	0.00129	CcSEcCtD
Desloratadine—Dyspnoea—Gemcitabine—lung cancer	0.000203	0.00129	CcSEcCtD
Desloratadine—Nausea—Vinblastine—lung cancer	0.000202	0.00128	CcSEcCtD
Desloratadine—Somnolence—Gemcitabine—lung cancer	0.000202	0.00128	CcSEcCtD
Desloratadine—Convulsion—Paclitaxel—lung cancer	0.000202	0.00128	CcSEcCtD
Desloratadine—Anorexia—Cisplatin—lung cancer	0.000202	0.00128	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—lung cancer	0.000202	0.00128	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000201	0.00128	CcSEcCtD
Desloratadine—Fatigue—Irinotecan—lung cancer	0.000201	0.00128	CcSEcCtD
Desloratadine—Pruritus—Vinorelbine—lung cancer	0.0002	0.00127	CcSEcCtD
Desloratadine—Mental disorder—Docetaxel—lung cancer	0.000199	0.00126	CcSEcCtD
Desloratadine—Myalgia—Paclitaxel—lung cancer	0.000199	0.00126	CcSEcCtD
Desloratadine—Erythema—Docetaxel—lung cancer	0.000198	0.00125	CcSEcCtD
Desloratadine—Decreased appetite—Gemcitabine—lung cancer	0.000198	0.00125	CcSEcCtD
Desloratadine—Nausea—Topotecan—lung cancer	0.000196	0.00125	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000196	0.00124	CcSEcCtD
Desloratadine—Fatigue—Gemcitabine—lung cancer	0.000196	0.00124	CcSEcCtD
Desloratadine—Nausea—Erlotinib—lung cancer	0.000194	0.00123	CcSEcCtD
Desloratadine—Dry mouth—Paclitaxel—lung cancer	0.000194	0.00123	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—lung cancer	0.000194	0.00123	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—lung cancer	0.000194	0.00123	CcSEcCtD
Desloratadine—Diarrhoea—Vinorelbine—lung cancer	0.000194	0.00123	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000193	0.00122	CcSEcCtD
Desloratadine—Infection—Etoposide—lung cancer	0.000193	0.00122	CcSEcCtD
Desloratadine—Gastrointestinal pain—Irinotecan—lung cancer	0.000191	0.00121	CcSEcCtD
Desloratadine—Anaphylactic shock—Paclitaxel—lung cancer	0.00019	0.00121	CcSEcCtD
Desloratadine—Oedema—Paclitaxel—lung cancer	0.00019	0.00121	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—lung cancer	0.00019	0.00121	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—lung cancer	0.000189	0.0012	CcSEcCtD
Desloratadine—Infection—Paclitaxel—lung cancer	0.000189	0.0012	CcSEcCtD
Desloratadine—Dyspnoea—Cisplatin—lung cancer	0.000189	0.0012	CcSEcCtD
Desloratadine—Dizziness—Vinorelbine—lung cancer	0.000187	0.00119	CcSEcCtD
Desloratadine—Nervous system disorder—Paclitaxel—lung cancer	0.000187	0.00118	CcSEcCtD
Desloratadine—Tachycardia—Paclitaxel—lung cancer	0.000186	0.00118	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—lung cancer	0.000185	0.00117	CcSEcCtD
Desloratadine—Anorexia—Etoposide—lung cancer	0.000185	0.00117	CcSEcCtD
Desloratadine—Abdominal pain—Irinotecan—lung cancer	0.000184	0.00117	CcSEcCtD
Desloratadine—Body temperature increased—Irinotecan—lung cancer	0.000184	0.00117	CcSEcCtD
Desloratadine—Decreased appetite—Cisplatin—lung cancer	0.000184	0.00117	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—lung cancer	0.000183	0.00116	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000183	0.00116	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—lung cancer	0.000182	0.00116	CcSEcCtD
Desloratadine—Infestation—Methotrexate—lung cancer	0.000182	0.00116	CcSEcCtD
Desloratadine—Anorexia—Paclitaxel—lung cancer	0.000181	0.00115	CcSEcCtD
Desloratadine—Vomiting—Vinorelbine—lung cancer	0.00018	0.00114	CcSEcCtD
Desloratadine—Body temperature increased—Gemcitabine—lung cancer	0.00018	0.00114	CcSEcCtD
Desloratadine—Rash—Vinorelbine—lung cancer	0.000178	0.00113	CcSEcCtD
Desloratadine—Dermatitis—Vinorelbine—lung cancer	0.000178	0.00113	CcSEcCtD
Desloratadine—Headache—Vinorelbine—lung cancer	0.000177	0.00112	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—lung cancer	0.000175	0.00111	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000173	0.0011	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—lung cancer	0.000173	0.0011	CcSEcCtD
Desloratadine—Somnolence—Etoposide—lung cancer	0.000173	0.00109	CcSEcCtD
Desloratadine—Cough—Docetaxel—lung cancer	0.000172	0.00109	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—lung cancer	0.000172	0.00109	CcSEcCtD
Desloratadine—Insomnia—Paclitaxel—lung cancer	0.000172	0.00109	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—lung cancer	0.000172	0.00109	CcSEcCtD
Desloratadine—Hypersensitivity—Irinotecan—lung cancer	0.000172	0.00109	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—lung cancer	0.000171	0.00109	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—lung cancer	0.00017	0.00108	CcSEcCtD
Desloratadine—Dyspnoea—Paclitaxel—lung cancer	0.00017	0.00108	CcSEcCtD
Desloratadine—Somnolence—Paclitaxel—lung cancer	0.000169	0.00107	CcSEcCtD
Desloratadine—Decreased appetite—Etoposide—lung cancer	0.000169	0.00107	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—lung cancer	0.000168	0.00107	CcSEcCtD
Desloratadine—Nausea—Vinorelbine—lung cancer	0.000168	0.00107	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—lung cancer	0.000168	0.00106	CcSEcCtD
Desloratadine—Dyspepsia—Paclitaxel—lung cancer	0.000168	0.00106	CcSEcCtD
Desloratadine—Body temperature increased—Cisplatin—lung cancer	0.000167	0.00106	CcSEcCtD
Desloratadine—Asthenia—Irinotecan—lung cancer	0.000167	0.00106	CcSEcCtD
Desloratadine—Fatigue—Etoposide—lung cancer	0.000167	0.00106	CcSEcCtD
Desloratadine—Decreased appetite—Paclitaxel—lung cancer	0.000165	0.00105	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—lung cancer	0.000165	0.00104	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000165	0.00104	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000164	0.00104	CcSEcCtD
Desloratadine—Fatigue—Paclitaxel—lung cancer	0.000164	0.00104	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—lung cancer	0.000164	0.00104	CcSEcCtD
Desloratadine—Asthenia—Gemcitabine—lung cancer	0.000163	0.00103	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—lung cancer	0.000162	0.00103	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—lung cancer	0.000161	0.00102	CcSEcCtD
Desloratadine—Oedema—Docetaxel—lung cancer	0.000161	0.00102	CcSEcCtD
Desloratadine—Pruritus—Gemcitabine—lung cancer	0.000161	0.00102	CcSEcCtD
Desloratadine—Infection—Docetaxel—lung cancer	0.00016	0.00102	CcSEcCtD
Desloratadine—Diarrhoea—Irinotecan—lung cancer	0.00016	0.00101	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—lung cancer	0.000159	0.00101	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—lung cancer	0.000158	0.001	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—lung cancer	0.000158	0.001	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—lung cancer	0.000158	0.001	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—lung cancer	0.000157	0.000998	CcSEcCtD
Desloratadine—Hypersensitivity—Cisplatin—lung cancer	0.000156	0.00099	CcSEcCtD
Desloratadine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000156	0.000987	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—lung cancer	0.000156	0.000986	CcSEcCtD
Desloratadine—Dizziness—Irinotecan—lung cancer	0.000154	0.000979	CcSEcCtD
Desloratadine—Urticaria—Etoposide—lung cancer	0.000154	0.000978	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—lung cancer	0.000154	0.000975	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—lung cancer	0.000153	0.000973	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—lung cancer	0.000153	0.000973	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—lung cancer	0.000153	0.000973	CcSEcCtD
Desloratadine—Asthenia—Cisplatin—lung cancer	0.000152	0.000964	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—lung cancer	0.000152	0.000963	CcSEcCtD
Desloratadine—Urticaria—Paclitaxel—lung cancer	0.000151	0.000959	CcSEcCtD
Desloratadine—Body temperature increased—Paclitaxel—lung cancer	0.00015	0.000954	CcSEcCtD
Desloratadine—Abdominal pain—Paclitaxel—lung cancer	0.00015	0.000954	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000149	0.000947	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—lung cancer	0.000149	0.000944	CcSEcCtD
Desloratadine—Vomiting—Irinotecan—lung cancer	0.000148	0.000941	CcSEcCtD
Desloratadine—Rash—Irinotecan—lung cancer	0.000147	0.000933	CcSEcCtD
Desloratadine—Dermatitis—Irinotecan—lung cancer	0.000147	0.000932	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000147	0.000932	CcSEcCtD
Desloratadine—Headache—Irinotecan—lung cancer	0.000146	0.000927	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—lung cancer	0.000146	0.000925	CcSEcCtD
Desloratadine—Diarrhoea—Cisplatin—lung cancer	0.000145	0.000919	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—lung cancer	0.000145	0.000917	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—lung cancer	0.000144	0.000912	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—lung cancer	0.000143	0.000909	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—lung cancer	0.000143	0.000909	CcSEcCtD
Desloratadine—Rash—Gemcitabine—lung cancer	0.000143	0.000909	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—lung cancer	0.000143	0.000908	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—lung cancer	0.000143	0.000907	CcSEcCtD
Desloratadine—Erythema—Methotrexate—lung cancer	0.000142	0.000903	CcSEcCtD
Desloratadine—Headache—Gemcitabine—lung cancer	0.000142	0.000903	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—lung cancer	0.000142	0.000901	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—lung cancer	0.000142	0.000899	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—lung cancer	0.000141	0.000892	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—lung cancer	0.00014	0.000889	CcSEcCtD
Desloratadine—Hypersensitivity—Paclitaxel—lung cancer	0.00014	0.000889	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000139	0.000883	CcSEcCtD
Desloratadine—Asthenia—Etoposide—lung cancer	0.000139	0.000883	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—lung cancer	0.000139	0.000883	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—lung cancer	0.000139	0.000882	CcSEcCtD
Desloratadine—Nausea—Irinotecan—lung cancer	0.000139	0.000879	CcSEcCtD
Desloratadine—Pruritus—Etoposide—lung cancer	0.000137	0.000871	CcSEcCtD
Desloratadine—Asthenia—Paclitaxel—lung cancer	0.000137	0.000866	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—lung cancer	0.000135	0.000856	CcSEcCtD
Desloratadine—Vomiting—Cisplatin—lung cancer	0.000135	0.000854	CcSEcCtD
Desloratadine—Pruritus—Paclitaxel—lung cancer	0.000135	0.000854	CcSEcCtD
Desloratadine—Rash—Cisplatin—lung cancer	0.000134	0.000847	CcSEcCtD
Desloratadine—Dermatitis—Cisplatin—lung cancer	0.000133	0.000846	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—lung cancer	0.000133	0.000842	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—lung cancer	0.000132	0.000837	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—lung cancer	0.000131	0.000834	CcSEcCtD
Desloratadine—Diarrhoea—Paclitaxel—lung cancer	0.00013	0.000826	CcSEcCtD
Desloratadine—Dizziness—Etoposide—lung cancer	0.000128	0.000814	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—lung cancer	0.000128	0.000809	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—lung cancer	0.000128	0.000809	CcSEcCtD
Desloratadine—Dizziness—Paclitaxel—lung cancer	0.000126	0.000798	CcSEcCtD
Desloratadine—Nausea—Cisplatin—lung cancer	0.000126	0.000798	CcSEcCtD
Desloratadine—Cough—Methotrexate—lung cancer	0.000124	0.000788	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—lung cancer	0.000124	0.000787	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—lung cancer	0.000123	0.000783	CcSEcCtD
Desloratadine—Vomiting—Etoposide—lung cancer	0.000123	0.000783	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—lung cancer	0.000123	0.000782	CcSEcCtD
Desloratadine—Rash—Etoposide—lung cancer	0.000122	0.000776	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—lung cancer	0.000122	0.000775	CcSEcCtD
Desloratadine—Headache—Etoposide—lung cancer	0.000122	0.000771	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—lung cancer	0.000121	0.000769	CcSEcCtD
Desloratadine—Vomiting—Paclitaxel—lung cancer	0.000121	0.000767	CcSEcCtD
Desloratadine—Rash—Paclitaxel—lung cancer	0.00012	0.000761	CcSEcCtD
Desloratadine—Dermatitis—Paclitaxel—lung cancer	0.00012	0.00076	CcSEcCtD
Desloratadine—Headache—Paclitaxel—lung cancer	0.000119	0.000756	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—lung cancer	0.000119	0.000754	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—lung cancer	0.000116	0.000737	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—lung cancer	0.000116	0.000734	CcSEcCtD
Desloratadine—Infection—Methotrexate—lung cancer	0.000115	0.000733	CcSEcCtD
Desloratadine—Nausea—Etoposide—lung cancer	0.000115	0.000731	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—lung cancer	0.000114	0.000724	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—lung cancer	0.000114	0.000723	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—lung cancer	0.000113	0.000719	CcSEcCtD
Desloratadine—Nausea—Paclitaxel—lung cancer	0.000113	0.000717	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—lung cancer	0.000111	0.000703	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—lung cancer	0.00011	0.0007	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—lung cancer	0.000109	0.000691	CcSEcCtD
Desloratadine—Cough—Doxorubicin—lung cancer	0.000108	0.000683	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—lung cancer	0.000107	0.000678	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—lung cancer	0.000107	0.000676	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000106	0.000672	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—lung cancer	0.000105	0.000667	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—lung cancer	0.000105	0.000666	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—lung cancer	0.000104	0.000657	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—lung cancer	0.000103	0.000655	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—lung cancer	0.000103	0.000651	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—lung cancer	0.000103	0.00065	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—lung cancer	0.000102	0.000649	CcSEcCtD
Desloratadine—Rash—Docetaxel—lung cancer	0.000102	0.000645	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—lung cancer	0.000102	0.000644	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—lung cancer	0.000101	0.000641	CcSEcCtD
Desloratadine—Headache—Docetaxel—lung cancer	0.000101	0.000641	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—lung cancer	0.000101	0.000638	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—lung cancer	0.000101	0.000638	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—lung cancer	0.0001	0.000637	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—lung cancer	0.0001	0.000636	CcSEcCtD
Desloratadine—Infection—Doxorubicin—lung cancer	0.0001	0.000634	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—lung cancer	9.87e-05	0.000626	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—lung cancer	9.82e-05	0.000623	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—lung cancer	9.6e-05	0.000609	CcSEcCtD
Desloratadine—Nausea—Docetaxel—lung cancer	9.58e-05	0.000608	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—lung cancer	9.51e-05	0.000603	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—lung cancer	9.24e-05	0.000586	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—lung cancer	9.19e-05	0.000583	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—lung cancer	9.19e-05	0.000583	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.17e-05	0.000582	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—lung cancer	9.1e-05	0.000577	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—lung cancer	8.97e-05	0.000569	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—lung cancer	8.95e-05	0.000568	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—lung cancer	8.86e-05	0.000562	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—lung cancer	8.75e-05	0.000555	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—lung cancer	8.69e-05	0.000551	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—lung cancer	8.68e-05	0.00055	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—lung cancer	8.56e-05	0.000543	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—lung cancer	8.34e-05	0.000529	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—lung cancer	8.23e-05	0.000522	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—lung cancer	8.22e-05	0.000522	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—lung cancer	8e-05	0.000507	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—lung cancer	7.96e-05	0.000505	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—lung cancer	7.96e-05	0.000505	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—lung cancer	7.95e-05	0.000504	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—lung cancer	7.69e-05	0.000488	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—lung cancer	7.42e-05	0.00047	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—lung cancer	7.39e-05	0.000469	CcSEcCtD
Desloratadine—Rash—Methotrexate—lung cancer	7.33e-05	0.000465	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—lung cancer	7.32e-05	0.000464	CcSEcCtD
Desloratadine—Headache—Methotrexate—lung cancer	7.28e-05	0.000462	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—lung cancer	7.22e-05	0.000458	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—lung cancer	7.12e-05	0.000452	CcSEcCtD
Desloratadine—Nausea—Methotrexate—lung cancer	6.91e-05	0.000438	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—lung cancer	6.89e-05	0.000437	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—lung cancer	6.66e-05	0.000422	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—lung cancer	6.4e-05	0.000406	CcSEcCtD
Desloratadine—Rash—Doxorubicin—lung cancer	6.35e-05	0.000403	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—lung cancer	6.34e-05	0.000402	CcSEcCtD
Desloratadine—Headache—Doxorubicin—lung cancer	6.31e-05	0.0004	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—lung cancer	5.98e-05	0.000379	CcSEcCtD
Desloratadine—CYP2C19—Metabolism—GCLC—lung cancer	1.23e-05	0.000161	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—POMC—lung cancer	1.23e-05	0.000161	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOA3—lung cancer	1.23e-05	0.000161	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.23e-05	0.000161	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—lung cancer	1.22e-05	0.000159	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKR1C1—lung cancer	1.21e-05	0.000159	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STK11—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ADCY1—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCG2—lung cancer	1.21e-05	0.000158	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2A6—lung cancer	1.2e-05	0.000158	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GCLC—lung cancer	1.2e-05	0.000158	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6R—lung cancer	1.2e-05	0.000157	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ADCY1—lung cancer	1.2e-05	0.000157	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCG2—lung cancer	1.2e-05	0.000157	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HPGDS—lung cancer	1.18e-05	0.000155	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ENO2—lung cancer	1.18e-05	0.000155	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.18e-05	0.000155	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—UGT1A1—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.18e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HPGDS—lung cancer	1.17e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ENO2—lung cancer	1.17e-05	0.000154	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ENO1—lung cancer	1.17e-05	0.000153	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FOXO3—lung cancer	1.17e-05	0.000153	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.16e-05	0.000153	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.16e-05	0.000152	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.15e-05	0.000151	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.15e-05	0.000151	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—lung cancer	1.15e-05	0.00015	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	1.14e-05	0.00015	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ENO1—lung cancer	1.14e-05	0.000149	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.14e-05	0.000149	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—lung cancer	1.14e-05	0.000149	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	1.14e-05	0.000149	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GNG11—lung cancer	1.14e-05	0.000149	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GCLC—lung cancer	1.13e-05	0.000148	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2A6—lung cancer	1.13e-05	0.000148	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.13e-05	0.000148	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GCLC—lung cancer	1.12e-05	0.000147	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.12e-05	0.000147	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.12e-05	0.000147	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AVP—lung cancer	1.09e-05	0.000143	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	1.09e-05	0.000143	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALDOA—lung cancer	1.08e-05	0.000142	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ENO1—lung cancer	1.07e-05	0.000141	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.07e-05	0.00014	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ENO1—lung cancer	1.07e-05	0.00014	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.06e-05	0.000139	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1R—lung cancer	1.05e-05	0.000138	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA3—lung cancer	1.05e-05	0.000138	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NQO1—lung cancer	1.04e-05	0.000136	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HES1—lung cancer	1.03e-05	0.000135	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.03e-05	0.000135	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2E1—lung cancer	1.02e-05	0.000134	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ADCY1—lung cancer	1.02e-05	0.000134	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCG2—lung cancer	1.02e-05	0.000134	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.01e-05	0.000133	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RAF1—lung cancer	1.01e-05	0.000133	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NQO1—lung cancer	1.01e-05	0.000132	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.01e-05	0.000132	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO2—lung cancer	1e-05	0.000131	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPGDS—lung cancer	1e-05	0.000131	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—lung cancer	1e-05	0.000131	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPP2R1B—lung cancer	9.95e-06	0.00013	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	9.9e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.82e-06	0.000129	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—lung cancer	9.72e-06	0.000127	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.65e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2E1—lung cancer	9.64e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2A6—lung cancer	9.6e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GCLC—lung cancer	9.6e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.57e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2E1—lung cancer	9.56e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—lung cancer	9.53e-06	0.000125	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—lung cancer	9.52e-06	0.000125	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB3—lung cancer	9.45e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—lung cancer	9.45e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—STK11—lung cancer	9.34e-06	0.000122	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.25e-06	0.000121	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.17e-06	0.00012	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—STK11—lung cancer	9.12e-06	0.000119	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO1—lung cancer	9.1e-06	0.000119	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—lung cancer	9.09e-06	0.000119	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.07e-06	0.000119	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—lung cancer	9.06e-06	0.000119	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.95e-06	0.000117	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR1—lung cancer	8.8e-06	0.000115	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.77e-06	0.000115	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—lung cancer	8.67e-06	0.000114	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—lung cancer	8.64e-06	0.000113	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—STK11—lung cancer	8.59e-06	0.000113	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—STK11—lung cancer	8.52e-06	0.000112	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—lung cancer	8.44e-06	0.000111	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAT—lung cancer	8.41e-06	0.00011	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOA1—lung cancer	8.36e-06	0.00011	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.36e-06	0.00011	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—lung cancer	8.29e-06	0.000109	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAT—lung cancer	8.21e-06	0.000108	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—lung cancer	8.18e-06	0.000107	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2E1—lung cancer	8.17e-06	0.000107	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—lung cancer	8.07e-06	0.000106	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMS—lung cancer	8.04e-06	0.000105	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8e-06	0.000105	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—lung cancer	7.95e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—lung cancer	7.94e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.91e-06	0.000104	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—lung cancer	7.88e-06	0.000103	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMS—lung cancer	7.84e-06	0.000103	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.83e-06	0.000103	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—lung cancer	7.75e-06	0.000102	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAT—lung cancer	7.74e-06	0.000101	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAT—lung cancer	7.67e-06	0.0001	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—lung cancer	7.63e-06	0.0001	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—lung cancer	7.63e-06	0.0001	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KIT—lung cancer	7.63e-06	0.0001	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—NRAS—lung cancer	7.63e-06	0.0001	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.62e-06	9.99e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGF—lung cancer	7.55e-06	9.89e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—lung cancer	7.53e-06	9.86e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—lung cancer	7.53e-06	9.86e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ERCC2—lung cancer	7.47e-06	9.78e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—lung cancer	7.46e-06	9.77e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMS—lung cancer	7.39e-06	9.68e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—lung cancer	7.35e-06	9.63e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMS—lung cancer	7.33e-06	9.6e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—lung cancer	7.31e-06	9.58e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—lung cancer	7.31e-06	9.57e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ERCC2—lung cancer	7.29e-06	9.55e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—STK11—lung cancer	7.28e-06	9.53e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—POMC—lung cancer	7.27e-06	9.52e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—lung cancer	7.24e-06	9.49e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—lung cancer	7.18e-06	9.4e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6R—lung cancer	7.09e-06	9.29e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CREBBP—lung cancer	7.08e-06	9.27e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—lung cancer	6.96e-06	9.11e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—lung cancer	6.93e-06	9.07e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ERCC2—lung cancer	6.87e-06	9e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—lung cancer	6.87e-06	8.99e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.83e-06	8.95e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ERCC2—lung cancer	6.81e-06	8.92e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAP2K1—lung cancer	6.76e-06	8.85e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—lung cancer	6.73e-06	8.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—lung cancer	6.71e-06	8.79e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	6.65e-06	8.71e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—lung cancer	6.57e-06	8.61e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAT—lung cancer	6.55e-06	8.58e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.52e-06	8.53e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOA1—lung cancer	6.46e-06	8.46e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—lung cancer	6.38e-06	8.35e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOA1—lung cancer	6.31e-06	8.26e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMS—lung cancer	6.26e-06	8.2e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—lung cancer	6.19e-06	8.11e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.19e-06	8.1e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	6.04e-06	7.91e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—lung cancer	6.01e-06	7.88e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAF1—lung cancer	5.99e-06	7.85e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOA1—lung cancer	5.94e-06	7.78e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—lung cancer	5.93e-06	7.76e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—lung cancer	5.9e-06	7.73e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOA1—lung cancer	5.89e-06	7.72e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—lung cancer	5.87e-06	7.68e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MTOR—lung cancer	5.85e-06	7.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—lung cancer	5.85e-06	7.66e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ERCC2—lung cancer	5.82e-06	7.62e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—lung cancer	5.76e-06	7.54e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.64e-06	7.39e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—lung cancer	5.62e-06	7.36e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—POMC—lung cancer	5.61e-06	7.35e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—lung cancer	5.59e-06	7.32e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—POMC—lung cancer	5.48e-06	7.18e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CREBBP—lung cancer	5.47e-06	7.16e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—lung cancer	5.43e-06	7.11e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—lung cancer	5.42e-06	7.11e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—lung cancer	5.38e-06	7.05e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.38e-06	7.04e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—lung cancer	5.37e-06	7.04e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—lung cancer	5.35e-06	7e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CREBBP—lung cancer	5.34e-06	6.99e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—lung cancer	5.24e-06	6.86e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—lung cancer	5.23e-06	6.85e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—lung cancer	5.18e-06	6.79e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—POMC—lung cancer	5.16e-06	6.76e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—POMC—lung cancer	5.12e-06	6.71e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—lung cancer	5.12e-06	6.7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—lung cancer	5.08e-06	6.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—lung cancer	5.07e-06	6.64e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—lung cancer	5.06e-06	6.63e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—lung cancer	5.06e-06	6.62e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOA1—lung cancer	5.03e-06	6.59e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CREBBP—lung cancer	5.03e-06	6.59e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—lung cancer	5e-06	6.54e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CREBBP—lung cancer	4.99e-06	6.53e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.93e-06	6.46e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EP300—lung cancer	4.82e-06	6.31e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.82e-06	6.31e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.77e-06	6.25e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—lung cancer	4.73e-06	6.19e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—lung cancer	4.71e-06	6.17e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SRC—lung cancer	4.69e-06	6.14e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—lung cancer	4.67e-06	6.11e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—lung cancer	4.6e-06	6.02e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.57e-06	5.98e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—lung cancer	4.52e-06	5.92e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—lung cancer	4.52e-06	5.92e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NRAS—lung cancer	4.51e-06	5.91e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—lung cancer	4.48e-06	5.87e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—lung cancer	4.41e-06	5.78e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—POMC—lung cancer	4.37e-06	5.73e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—lung cancer	4.37e-06	5.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.32e-06	5.66e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CREBBP—lung cancer	4.26e-06	5.58e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—lung cancer	4.2e-06	5.5e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.16e-06	5.44e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.12e-06	5.4e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—lung cancer	4.12e-06	5.39e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—lung cancer	4.11e-06	5.38e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—lung cancer	4.08e-06	5.35e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—lung cancer	4.04e-06	5.29e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—lung cancer	3.99e-06	5.22e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—lung cancer	3.91e-06	5.12e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—lung cancer	3.88e-06	5.08e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—lung cancer	3.81e-06	4.99e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—EP300—lung cancer	3.72e-06	4.88e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—EP300—lung cancer	3.63e-06	4.76e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—lung cancer	3.59e-06	4.7e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.57e-06	4.67e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—lung cancer	3.56e-06	4.66e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—lung cancer	3.52e-06	4.61e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—lung cancer	3.49e-06	4.57e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—lung cancer	3.45e-06	4.52e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—EP300—lung cancer	3.43e-06	4.49e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—EP300—lung cancer	3.4e-06	4.45e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—lung cancer	3.3e-06	4.32e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—lung cancer	3.16e-06	4.14e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—lung cancer	3.04e-06	3.99e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—lung cancer	2.91e-06	3.82e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—EP300—lung cancer	2.9e-06	3.8e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.75e-06	3.61e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—lung cancer	2.69e-06	3.52e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.53e-06	3.32e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.51e-06	3.29e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—lung cancer	2.25e-06	2.95e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—lung cancer	2.2e-06	2.88e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—lung cancer	2.15e-06	2.81e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—lung cancer	2.07e-06	2.71e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—lung cancer	2.05e-06	2.69e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—lung cancer	1.75e-06	2.3e-05	CbGpPWpGaD
